Inovotion has developed a unique in vivo approach for the early identification of low-value molecules in drug discovery for oncology, based on a new type of chick-egg assay for efficacy and toxicity. These tests are easily accessible for wide range of users : chemists and biologists in small biotechs, academic labs, and big pharmaceutical companies. Our assays are faster, more complete, more reliable and less expensive than classical models. We make it much easier to get through the in vivo assay stage to the next step, faster and without going over budget.
Inovotion’s new approach adds an intermediate step in the drug discovery process, between in vitro testing and the pre-clinical assays on mice, allowing rapid validation of potential new drugs and a reduction in the level of risk in the overall value chain. Our assays are currently dedicated to evaluating efficacy and toxicity during lead validation, lead optimization, and target validation. This very accessible technology reduces the time and cost needed for in vivo testing, allowing rapid GO/NO GO decisions. It opens up terrific new perspectives for research projects.
5 avenue du Grand Sablon
38700 LA TRONCHE